Literature DB >> 21495232

Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.

Srinivas Kondalsamy-Chennakesavan1, Stijn van Vugt, Karen Sanday, Jim Nicklin, Russell Land, Lewis Perrin, Alex Crandon, Andreas Obermair.   

Abstract

INTRODUCTION: Concurrent uterine lesions or an irregular endomyometrial junction can make accurate assessment of depth of myometrial invasion (DOI) and percentage of myometrial invasion (%MI) difficult, leading to patients being staged and or treated suboptimally. An alternative measurement, known as the tumor-free distance (TFD), which measures the distance between maximal myometrial invasion and the uterine serosa, has been proposed. Previous studies comparing the predictive abilities of DOI and TFD were underpowered and inconclusive. Our objective was to compare TFD, DOI, and %MI as predictors for lymph node involvement in surgically staged endometrial cancer patients.
METHODS: Patients with endometrioid adenocarcinoma of the endometrium treated between January 1997 and December 2007 were included. Tumor-free distance, DOI, and %MI were evaluated along with other pathological variables to determine their predictive ability for nodal involvement. Depth of myometrial invasion was measured between the endomyometrial junction and the maximal myometrial invasion. Tumor-free distance was calculated by subtracting the DOI from myometrial thickness (MT). Percentage MI was derived by dividing DOI by MT and expressed as a percentage of MT invaded. These 3 variables were transformed to z scores, and their ability to predict nodal involvement was compared.
RESULTS: A total of 338 patients were eligible for analysis. Mean (SD) MT was 18.7 (5.9) mm. Median DOI was 6 mm, and median TFD was 10.3 mm. On univariate analysis, all 3 variables showed significant associations with nodal involvement. On multivariate analysis, after adjusting for lymphovascular space invasion, cervical involvement, serosal/adnexal involvement, grade, %MI, and TFD, DOI retained its statistical significance along with lymphovascular space invasion and cervical involvement.
CONCLUSIONS: Depth of myometrial invasion predicts nodal involvement independently when compared with TFD.

Entities:  

Mesh:

Year:  2010        PMID: 21495232     DOI: 10.1111/igc.0b013e3181ef0a31

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  Pre-operative MRI staging of endometrial cancer in a multicentre cancer network: can we match single centre study results?

Authors:  N D Soneji; N Bharwani; A Ferri; V Stewart; A Rockall
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

2.  Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Authors:  Priya Bhosale; Jingfei Ma; Revathy Iyer; Preetha Ramalingam; Wei Wei; Pamela Soliman; Michael Frumovitz; Vikas Kundra
Journal:  J Magn Reson Imaging       Date:  2015-07-16       Impact factor: 4.813

3.  A study of pelvic and para-aortic lymph node involvement in surgically staged endometrioid carcinoma of endometrium.

Authors:  Rekha B Raghavendrachar; Julian Crasta; Premalatha T Siddartha; Elizabeth M Vallikad
Journal:  J Obstet Gynaecol India       Date:  2013-04-11

4.  A cohort study evaluating paraaortic lymphadenectomy in endometrial cancer.

Authors:  Haiyan Zhang; Zhi Zuo; Ye Wang; Li Wang; Zhiling Zhu
Journal:  Oncol Lett       Date:  2012-09-17       Impact factor: 2.967

5.  Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer.

Authors:  Raoudha Doghri; Salma Chaabouni; Yoldez Houcine; Lamia Charfi; Nadia Boujelbene; Maha Driss; Karima Mrad
Journal:  Mol Clin Oncol       Date:  2018-05-16

6.  Reproducibility of measurement of myometrial invasion in endometrial carcinoma.

Authors:  Louis J M van der Putten; Koen van de Vijver; Carla Bartosch; Ben Davidson; Sonia Gatius; Xavier Matias-Guiu; W Glenn McCluggage; Gemma Toledo; Anneke A M van der Wurff; Johanna M A Pijnenborg; Leon F A G Massuger; Johan Bulten
Journal:  Virchows Arch       Date:  2016-10-27       Impact factor: 4.064

7.  Is Tumor-Free Distance an Independent Prognostic Factor for Early-Stage Endometrioid Endometrial Cancer?

Authors:  Tufan Oge; Duygu Kavak Comert; Yusuf Cakmak; Deniz Arık
Journal:  J Oncol       Date:  2020-04-14       Impact factor: 4.375

8.  MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer.

Authors:  Julie Andrea Dybvik; Kristine E Fasmer; Sigmund Ytre-Hauge; Jenny Hild Aase Husby; Øyvind O Salvesen; Ingunn Marie Stefansson; Camilla Krakstad; Jone Trovik; Ingfrid S Haldorsen
Journal:  Insights Imaging       Date:  2022-01-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.